CAS No.: | 52232-67-4 |
---|---|
Formula: | C181h291n55o51s 2 |
Type: | Pharmaceutical Intermediates |
Appearance: | Powder |
Quality: | Technical |
Colour: | White |
Samples: |
---|
Customization: |
---|
Suppliers with verified business licenses
Introduction:
Teriparatide Acate is a synthetic of human parathyroid hormone (PTH). It is derived from the 34 amino acids of the full-length PTH and is used in the treatment of osteoporosis. Teriparatide Acetate is commonly marketed under the brand name Forteo.
Function:
Teriparatide Acetate is primarily used to increase bone formation and improve bone density in individuals with osteoporosis. It works by stimulating osteoblast activity, which are the cells responsible for bone formation. By promoting new bone growth, Teriparatide Acetate helps to reduce the risk of fractures and strengthens the skeletal structure. Additionally, it increases calcium absorption from the intestines and enhances renal reabsorption of calcium, contributing to overall bone health.
Application:
Teriparatide Acetate is administered through daily subcutaneous injections, typically for a duration of up to 24 months. It is prescribed to postmenopausal women and men with a high risk of fractures or those who have failed or are intolerant to other available osteoporosis treatments. Teriparatide Acetate is also used in the treatment of glucocorticoid-induced osteoporosis, a condition caused by long-term use of glucocorticoid medications. Additionally, it may be prescribed to individuals with primary or hypogonadal osteoporosis. Regular monitoring of bone density and calcium levels is essential during treatment with Teriparatide Acetate to ensure its efficacy and safety.
1. Are you a manufacturer or trading company?
A: We are a manufacturer and welcome to visit our factory.Suppliers with verified business licenses